Persistent Asset Partners LTD Kal Vista Pharmaceuticals, Inc. Transaction History
Persistent Asset Partners LTD
- $119 Billion
- Q1 2025
A detailed history of Persistent Asset Partners LTD transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 34,098 shares of KALV stock, worth $413,267. This represents 0.33% of its overall portfolio holdings.
Number of Shares
34,098
Previous 41,952
18.72%
Holding current value
$413,267
Previous $374 Million
5.27%
% of portfolio
0.33%
Previous 0.31%
Shares
2 transactions
Others Institutions Holding KALV
# of Institutions
139Shares Held
54.4MCall Options Held
1.38MPut Options Held
6K-
Vr Adviser, LLC New York, NY6.7MShares$81.3 Million18.68% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$59.9 Million3.7% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$59.5 Million2.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$59.2 Million3.55% of portfolio
-
Vestal Point Capital, LP New York, NY4.75MShares$57.6 Million3.92% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $298M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...